Zhao, X., Wang, M., Wen, Z., Lu, Z., Cui, L., Fu, C., Xue, H., Liu, Y., & Zhang, Y
Resources We Trust Cleveland Clinic: Answering Your Questions About GLP-1s Mayo Clinic: Health Benefits of Semaglutide Beyond Weight Loss Harvard Health Publishing: GLP-1 Diabetes and Weight-Loss Drug Side Effects University of Missouri: Thinking About Microdosing GLP-1
This process involves your doctor submitting documentation proving you have a BMI of 30 or higher (obesity), or a BMI of 27 or higher with at least one weight-related comorbidity (high blood pressure, type 2 diabetes, high cholesterol, sleep apnea, etc.), and documentation of previous weight loss attempts (diet, exercise programs, sometimes previous medications)
If they remain problematic, consider the medical evaluation outlined earlier (SIBO testing, H
Together with other modifications in the peptide sequence, this leads to a tirzepatide half-life of over five days [1, 4]
Finally, HumeCare's page describes an "exit strategy" phase once you reach your target - a personalized transition plan aimed at maintaining your results after you taper off medication, rather than assuming you'll stay on the program indefinitely